Targeted allele-specific FGFR2 knockdown via human recombinant ferritin nanoparticles for personalized treatment of Crouzon syndrome

Federica Tiberio(Università Cattolica del Sacro Cuore), Wanda Lattanzi(Università Cattolica del Sacro Cuore)

Molecular Therapy — Nucleic Acids

December 12, 2024

10.1016/j.omtn.2024.102427

Cited by 6

Related Papers

A smart nanocomposite bioactive ink for controlled siRNA delivery in calvarial mesenchymal stromal cells as a minimally invasive treatment for craniosynostosis

|Regenerative Biomaterials|2025|1